Metabolic Disorders Surpass Viral Hepatitis as Leading Drivers of Global Liver Cancer Surge

A new study reveals that obesity and diabetes are replacing hepatitis as the top causes of liver cancer, with cases expected to hit 1.5 million by 2050.

By: AXL Media

Published: Apr 14, 2026, 11:50 AM EDT

Source: Information for this report was sourced from EurekAlert!

The Changing Face of a Global Health Crisis

Primary liver cancer remains the third leading cause of cancer-related mortality worldwide, with nearly 870,000 new cases recorded in 2022. However, the underlying causes of the disease are undergoing a radical transformation. A joint study by Fudan University’s Liver Cancer Institute and Massachusetts General Hospital, published in Portal Hypertension & Cirrhosis, highlights a transition from infectious triggers to metabolic ones. While the world has made significant strides in controlling Hepatitis B and C, the rise of metabolic dysfunction-associated steatotic liver disease (MASLD) is creating a "hidden epidemic" that threatens to undo decades of progress in oncology.

The Rise of Metabolic Risk Factors

The research team, led by Professor Jian Zhou and Professor Dan G. Duda, integrated data from global databases like GLOBOCAN 2022 to identify emerging drivers. Their findings indicate that lifestyle-related factors—including obesity, Type 2 diabetes, poor diet, and physical inactivity—are now the primary engines of liver cancer growth in many regions. This shift is particularly evident in China, which carries over 40% of the global burden. As metabolic disorders become more prevalent, the absolute number of liver cancer cases is projected to rise by nearly 75% by 2050 if current lifestyle trends are not addressed.

[Image: Schematic of liver cancer transition from viral to metabolic drivers]

Regional Disparities and Preventable Cases